Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: Report of two cases

Clinical Transplantation, Supplement

Volumn 19, Issue 14, 2005, Pages 59-64

  Masutani, Kohsuke ^a   Katafuchi, Ritsuko ^b   Ikeda, Hirofumi ^a   Yamamoto, Hirofumi ^a   Motoyama, Kentaro ^a   Sugitani, Atsushi ^a,c   Kanai, Hidetoshi ^d   Kumagai, Harumitsu ^d   Hirakata, Hideki ^c   Tanaka, Masao ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Low density lipoprotein apheresis; Plasma exchange; Type 1 membranoproliferative glomerulonephritis

Indexed keywords

ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPYRIDAMOLE; HEPARIN; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; WARFARIN;

ACUTE GRAFT REJECTION; ADULT; APHERESIS; ARTICLE; CASE REPORT; CHRONIC ALLOGRAFT NEPHROPATHY; DETERIORATION; DRUG PULSE THERAPY; FOAM CELL; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; LIVING DONOR; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RELAPSE; REMISSION; RENAL GRAFT DYSFUNCTION;

EID: 22244450678     PISSN: 13996738     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00397.x     Document Type: Article

References (17)

1. Andresdottir MB, Assmann KJM, Hoitsma AJ, Koene RAP, Wetzels JFM. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation. Analysis of the incidence, risk factors, and impact on graft survival. Transplantation 1997: 63: 1628.
2. Lien YHH, Scott K. Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. Am J Kidney Dis 2000: 35: 539.
3. Saxena R, Frankel WL, Sedmak DD, Falkenhain ME, Cosio FG. Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: Successful treatment with plasmapheresis. Am J Kidney Dis 2000: 35: 749.
4. Ramos EL, Tisher CC. Recurrent diseases in kidney transplants. Am J Kidney Dis 1994: 24: 142.
5. Zimmerman SW. Increased urinary protein secretion in the rat produced by serum from a patient with recurrent focal glomerulosclerosis after renal transplantation. Clin Nephrol 1984: 22: 32.
6. Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991: 46: 827.
7. Mitwalli AH. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis? Nephrol Dial Transplant 1998: 13: 1524.
8. Ranchin B, Gagnadoux MF, Broyer M et al. Value of cyclosporine in the treatment of recurrence of nephrosis after renal transplantation. Nephrologie 1996: 17: 441.
9. Berthoux FC, Ducret F, Colon S, Blanc-Brunat N, Zech PY, Traeger J. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frequency of recurrent glomerulonephritis and hypocomplementemia. Kidney Int Suppl 1975: 7: S323.
10. Sharma M, Sharma R, McCarthy ET, Savin VJ. "The FSGS factor": enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999: 10: 552.
11. Prafhan M, Petro J, Palmer J, Meyers K, Baluarte HJ. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003: 18: 934.
12. Ideura T, Hora K, Kaneko Y et al. Effect of low-density lipoprotein-apheresis on nephritic syndrome due to membranous nephropathy in renal allograft: a case report. Transplant Proc 2000: 32: 223.
13. Yanagisawa T, Otsubo O, Nozaki H et al. Massive proteinuria after renal transplantation treated with LDL-apheresis. Transplant Proc 1996: 28: 1482.
14. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 1994: 9: 257.
15. Kojima S, Harada-Shiba M, Toyota Y et al. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 1992: 15: 185.
16. Haas M, Boehmig GA, Leko-Mohr Z et al. Peri-operative immunoadsorption in sensitized renal transplant recipients. Nephrol Dial Transplant 2002: 17: 1503.
17. Büssemaker E, Passauer J, Franz T, Gross P. Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome. Nephrol Dial Transplant 2001: 16: 1270.